[1. Pacàk K, Palkovits M. Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders. Endo Rev. 2001; 22(4):502-548. https://doi.org/10.1210/edrv.22.4.0436.10.1210/edrv.22.4.0436]Search in Google Scholar
[2. Butler RK, Finn DP. Stress-induced analgesia. Progress in Neurobiology. 2009; 88(3):184-202. https://doi.org/10.1016/j.pneurobio.2009.04.003.10.1016/j.pneurobio.2009.04.003]Search in Google Scholar
[3. Galina ZH, Sutherland CJ, Amit Z. Effects of heat-stress on behavior and the pituitary adrenal axis in rats. Pharmacol Biochem Behav. 1983; 19(2):251-256. https://doi.org/10.1016/0091-3057(83)90048-5.10.1016/0091-3057(83)90048-5]Search in Google Scholar
[4. Finn DP. Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance. Immunobiology. 2010; 215(8):629-646. https://doi.org/10.1016/j.imbio.2009.05.011.10.1016/j.imbio.2009.05.01119616342]Search in Google Scholar
[5. Cury Y, Picolo G, Pacciari GV, et al. Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. Nitric Oxide. 2011; 25(3):243-254. https://doi.org/doi:10.1016/j.niox.2011.06.004.10.1016/j.niox.2011.06.00421723953]Search in Google Scholar
[6. Devane WA, Dysarz FA, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34:605-613.]Search in Google Scholar
[7. Matsuda LA, Lolait SJ, Brownstein M et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346(6284):561-564. https://doi.org/10.1038/346561a0.10.1038/346561a02165569]Search in Google Scholar
[8. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993; 365:61-65. https://doi.org/10.1038/365061a0.10.1038/365061a07689702]Search in Google Scholar
[9. Svíženská I, Dubový P, Šulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures – a short review, Pharmacol Biochem Behav. 2008; 90(4):501-511. https://doi.org/10.1016/j.pbb.2008.05.010.10.1016/j.pbb.2008.05.01018584858]Search in Google Scholar
[10. Herkenham M, Lynn AB, Johnson MR, et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991; 11(2):563-583. https://doi.org/10.1523/JNEUROSCI.11-02-00563.1991.10.1523/JNEUROSCI.11-02-00563.1991]Search in Google Scholar
[11. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system, in: R.G. Pertwee (Ed.), Cannabinoids. Handbook of Experimental Pharmacology 2005; vol. 168, Springer, Berlin, Heidelberg, pp. 299-325. https://doi.org/10.1007/3-540-26573-2_10.10.1007/3-540-26573-2_1016596779]Search in Google Scholar
[12. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992; 258(5090):946-949. https://doi.org/10.1126/science.1470919.10.1126/science.14709191470919]Search in Google Scholar
[13. Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995; 215(1):89-97. https://doi.org/10.1006/bbrc.1995.2437.10.1006/bbrc.1995.24377575630]Search in Google Scholar
[14. Wilson RI and Nicoll RA. Endocannabinoid signaling in the brain. Science. 2002; 296:678-682. https://doi.org/10.1126/science.1063545.10.1126/science.106354511976437]Search in Google Scholar
[15. Starowicz K, Malek N, Przewlocka B. Cannabinoid receptors and pain. WIREs: Membr. Transp. Signal. 2013; 2(3):121-132. https://doi.org/10.1002/wmts.83.10.1002/wmts.83]Search in Google Scholar
[16. Nakazi MU, Bauer T, Nickel M, et al. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000; 361(1):19-24. https://doi.org/10.1007/s002109900147.10.1007/s00210990014710651142]Search in Google Scholar
[17. Walker JM, Huang SM, Strangman NM, et al. Pain modulation by release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96(21):12198-12203. https://dx.doi.org/10.1073%2Fpnas.96.21.12198.10.1073/pnas.96.21.121981843510518599]Search in Google Scholar
[18. Gorzalka BB, Hill MN, Hillard CJ. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev. 2008; 32(6):1152-1160. https://dx.doi.org/10.1016/j.neubiorev.2008.03.004.10.1016/j.neubiorev.2008.03.00418433869]Search in Google Scholar
[19. Woodhams SG, Chapman V, Finn DP et al. The cannabinoid system and pain, Neuropharmacology 2017; online, doi: 10.1016/j. neuropharm.2017.06.015.]Search in Google Scholar
[20. Li Y, Zhang L, Wu Y, Zheng Q, et al. Cannabinoids-induced peripheral analgesia depends on activation of BK channels. Brain Research 2019; 17(11):23-28.10.1016/j.brainres.2019.01.00730615887]Search in Google Scholar
[21. Maurya N, Velmurugan BK. Therapeutic applications of cannabinoids. Chemico-Biological Interactions 2018; 293:77-88. https://dx.doi.org/10.1016/j.cbi.2018.07.018.10.1016/j.cbi.2018.07.01830040916]Search in Google Scholar
[22. Paradise WA, Vesper BJ, Goel A, et al. Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin. In J Mol Sci. 2010; 11(7):2715-2745. https://dx.doi.org/10.3390/ijms11072715.10.3390/ijms11072715292056320717533]Search in Google Scholar
[23. Freire MA, Guimaraes JS, Leal WG, et al. Pain modulation by nitric oxide in the spinal cord. Front Neurosci. 2009; 3(2):175-181. https://dx.doi.org/10.3389%2Fneuro.01.024.2009.10.3389/neuro.01.024.2009275162320011139]Search in Google Scholar
[24. Esplugues JV. NO as a signalling molecule in the nervous system. Br J Pharmacol. 2002; 135:1079-1095. https://dx.doi.org/10.1038/sj.bjp.0704569.10.1038/sj.bjp.0704569157323311877313]Search in Google Scholar
[25. Iziara FF, Galdino PM, De Oliveira LP, et al. Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021). Nitric Oxide. 2015; 47:17-24. https://dx.doi.org/10.1111/cbdd.12838.10.1111/cbdd.1283827526659]Search in Google Scholar
[26. Hervera A, Leánez S, Pol O. The inhibition of the nitric oxide–cGMP–PKG–JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain. Europ J of Pharmac. 2012; 685(1-3):42-51. https://dx.doi.org/10.1016/j.ejphar.2012.04.009.10.1016/j.ejphar.2012.04.00922546233]Search in Google Scholar
[27. Luce V, Solari JF, Rettori V, et al. The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide. Regulatory Peptides. 2014; 188:31-39. https://doi.org/10.1016/j.regpep.2013.12.004.10.1016/j.regpep.2013.12.00424342802]Search in Google Scholar
[28. Andre CM, Hausman J-F, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front. Plant Sci. 2016; online, https://doi.org/10.3389/fpls.2016.00019.10.3389/fpls.2016.00019474039626870049]Search in Google Scholar
[29. Mastinu A, Premoli M, Ferrari-Toninelli G, et al. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. Horm. Mol. Biol. Clin. Investig. 2018; online, https://doi.org/10.1515/hmbci-2018-0013.10.1515/hmbci-2018-001329601300]Search in Google Scholar
[30. Bonini SA, Premolia M, Tambaro S, et al. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol 2018; 227:300-315. https://doi.org/10.1016/j.jep.2018.09.004.10.1016/j.jep.2018.09.00430205181]Search in Google Scholar
[31. Seth, B. Non-opioid analgesics. Anaesthesia & Intensive Care Medicine 2019; 20(8):456-459. doi:10.1016/j.mpaic.2019.06.001.10.1016/j.mpaic.2019.06.001]Search in Google Scholar
[32. Zou S, Kumar U. Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus. Brain research 2015; 1622:114-126. https://doi.org/10.1016/j.brainres.2015.06.021.10.1016/j.brainres.2015.06.02126115586]Search in Google Scholar
[33. Bujalska-Zadrozny M, de Corde´ A, Pawlik K. Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy. Pharmacol Reports. 2015; 67(2):209-216. https://doi.org/10.1016/j.pharep.2014.08.023.10.1016/j.pharep.2014.08.02325712641]Search in Google Scholar
[34. Bujalska M. Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy. Pharmacology. 2008; 82(3):193-200. https://doi.org/10.1159/000156485.10.1159/00015648518810243]Search in Google Scholar
[35. Szabadits E, Cserep C, Ludanyi A, et al. Hippocampal GABAergic synapses possess the molecular machinery for retrograde nitricoxide signaling. J. Neurosci. 2007; 27:8101-8111.10.1523/JNEUROSCI.1912-07.2007667273417652601]Search in Google Scholar
[36. Dvorácskó S, Tömböly C, Berkecz R, Keresztes A. Investigation of receptor binding and functional characteristics of hemopressin (1-7). Neuropeptides 2016; 58:15-22. doi: 10.1016/j.npep.2016.02.001.10.1016/j.npep.2016.02.00126895730]Search in Google Scholar
[37. Wang P, Zheng T, Zhang M, et al. Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice. Brain Research Bulletin 2018; 139:48-55. https://doi.org/10.1016/j.brainresbull.2018.02.003.10.1016/j.brainresbull.2018.02.00329425797]Search in Google Scholar